Rowley Law PLLC is investigating potential securities law violations by Perspecta, Inc. (NYSE: PRSP) and its board of directors concerning the proposed acquisition of the company by Peraton, a portfolio company of Veritas Capital. Stockholders will receive $29.35 for each share of Perspecta stock that they hold. The transaction is valued at approximately $7.1 billion […]
Rowley Law PLLC is investigating potential securities law violations by ProSight (NYSE: PROS) and its board of directors concerning the proposed acquisition of the company by TowerBrook Capital Partners L.P. and Further Global Capital Management. Stockholders will receive $12.85 per share of ProSight common stock that they hold. The transaction is valued at approximately $586 […]
Rowley Law PLLC is investigating potential securities law violations by Cantel Medical Corporation (NYSE: CMD) (“Cantel”) and its board of directors concerning the proposed acquisition of the company by Steris Plc (NYSE: STE) (“Steris”). Under the terms of the agreement, Cantel common stockholders will receive approximately $16.93 in cash and 0.33787 of a Steris ordinary […]
Rowley Law PLLC is investigating potential securities law violations by Change Healthcare Inc. (NASDAQ: CHNG) and its board of directors concerning the proposed acquisition of the company by a UnitedHealth Group (NYSE: UNH) company. Stockholders will receive $25.75 for each share of Change Healthcare stock that they hold. The transaction is expected to close in […]
Rowley Law PLLC is investigating potential securities law violations by Boston Private Financial Holdings, Inc. (NASDAQ: BPFH) and its board of directors concerning the proposed acquisition of the company by SVB Financial Group (NASDAQ: SIVB). Stockholders will receive $2.10 and 0.0228 shares of SVB Financial Group common stock for each share of Boston Private stock […]
Rowley Law PLLC is investigating potential securities law violations by Magellan Health, Inc. (NASDAQ: MGLN) and its board of directors concerning the proposed acquisition of the company by Centene Corporation (NYSE: CNC). Stockholders will receive $95.00 for each share of Magellan Health stock that they hold. The transaction is valued at approximately $2.2 billion and […]
